Systemic antiviral drugs. Other antiviral drugs
An antiviral agent that specifically inhibits influenza A and B viruses, including the highly pathogenic subtypes A (H1N1) pdm09 and A (H5N1). According to the mechanism of antiviral action, Imustat belongs to fusion inhibitors, interacts with viral haemagglutinin and prevents the fusion of viral lipid membrane and cell membranes.
Prevention and treatment of Influenza A and B.
For use in adults. For oral administration before meals. The single dose is 200 mg.
in case of direct contact with flu patients: 200 mg once daily for 10-14 days;
during a flu epidemic: 200 mg twice a week for 3 weeks.
For influenza treatment: 200 mg 4 times a day (every 6 hours) for 5 days.
The maximum daily dose is 800 mg.